Improving early childhood care and development, HIV-testing, treatment and support, and nutrition in Mokhotlong, Lesotho: study protocol for a cluster randomized controlled trial
This study provides a unique opportunity to assess the potential of an integrated early childhood development intervention to prevent or mitigate developmental delays in children living in a context of extreme poverty and high HIV rates in rural Lesotho. This paper presents the intervention content and research protocol for the study.Trial registrationThe Mphatlalatsane: Early Morning Star trial is registered on the International Standard Randomized Controlled Trial Number database, registration numberISRCTN16654287; the trial was registered on 3 July 2015. (Source: Trials)
Source: Trials - November 8, 2016 Category: Research Source Type: clinical trials
Evaluating Newly Approved Drugs for Multidrug-resistant TB
Condition: Tuberculosis, Multidrug-ResistantInterventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Clofazimine; Drug: Levofloxacin; Drug: Moxifloxacin; Drug: Linezolid; Drug: PyrazinamideSponsors: Médecins Sans Frontières France; Partners in Health; Harvard Medical School; Epicentre; Institute of Tropical Medicine, Belgium; Ministry of Health, Kyrgyzstan; National Center for Tuberculosis Problems, Kazakhstan; Ministry of Health, Lesotho; National Center for Tuberculosis and Lung Diseases, Georgia; Socios En Salud, PeruNot yet recruitin...
Source: ClinicalTrials.gov - April 25, 2016 Category: Research Source Type: clinical trials
Evaluating Newly Approved Drugs for Multidrug-resistant TB
Condition: Tuberculosis, Multidrug-ResistantInterventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Clofazimine; Drug: Levofloxacin; Drug: Moxifloxacin; Drug: Linezolid; Drug: PyrazinamideSponsors: Médecins Sans Frontières France; Partners in Health; Harvard Medical School; Epicentre; Institute of Tropical Medicine, Belgium; Ministry of Health, Kyrgyzstan; National Center for Tuberculosis Problems, Kazakhstan; Ministry of Health, Lesotho; National Center for Tuberculosis and Lung Diseases, Georgia; Socios En Salud, PeruNot yet recruitin...
Source: ClinicalTrials.gov - April 25, 2016 Category: Research Source Type: clinical trials
Evaluating Newly Approved Drugs for Multidrug-resistant TB
Condition: Tuberculosis, Multidrug-ResistantInterventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Clofazimine; Drug: Levofloxacin; Drug: Moxifloxacin; Drug: Linezolid; Drug: PyrazinamideSponsors: Médecins Sans Frontières France; Partners in Health; Harvard Medical School; Epicentre; Institute of Tropical Medicine, Belgium; Ministry of Health, Kyrgyzstan; National Center for Tuberculosis Problems, Kazakhstan; Ministry of Health, Lesotho; National Center for Tuberculosis and Lung Diseases, Georgia; Socios En Salud, PeruNot yet recruitin...
Source: ClinicalTrials.gov - April 25, 2016 Category: Research Source Type: clinical trials
